Bonk Inc

Bonk Inc(BNKK)股票分析

$1.120

+0.020 (+1.82%)收盤時

Loading chart…
最高
1.140
開盤
1.110
成交量加權均價
1.11
成交量
74.38K
市值
—
最低
1.060
成交金額
82.31K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Bonk, Inc., formerly Safety Shot, Inc., is a wellness and dietary supplement company. The Company has developed Sure Shot, which is a patented wellness product that lowers blood alcohol content. In approximately 30 minutes, this product helps the body break down alcohol. Its bottles and stick packs are sold direct-to-consumer (D2C) and via retail partners. D2C orders through the Sure Shot Website are fulfilled via a 3PL with additional sales through online outlets. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon. It has also introduced business-to-business sales of Sure Shot to distributors, retailers, restaurants and bars. It also makes energy beverages with yerba mate and other plant-based ingredients. Its energy beverages are zero calorie, zero sugar, non-genetically modified organism, vegan, kosher, keto-friendly, paleo-approved, gluten-free and diabetic-friendly. The Company is focused on building a digital asset treasury.

AI 分析 of Bonk Inc (BNKK)

持有

Bonk Inc (BNKK) is currently trading at $1.085, which is significantly lower than its 200-day simple moving average of $2.18, indicating a bearish trend. The RSI is at 29.83, suggesting the stock is oversold, which could indicate a potential reversal. However, the stock has seen a year-to-date decline of 63.10%, and its forward P/E ratio is at 0, reflecting uncertainty about future earnings. The recent insider purchase by President Mitchell Rudy at $1.37 shows some confidence in the stock, but the overall financial performance remains concerning, with a gross margin of only 33.61% in Q2 2026 and a net income loss of $6.05 million in the same quarter. The main risk is the continued decline in stock performance, with a 5-day change of -10.33%.

估值指標

Bonk Inc(BNKK)目前預期本益比為 0.00,5 年平均預期本益比為 0.57。

預期本益比

嚴重低估
5 年均值 P/E
0.57
目前P/E
0.00
高估
0.81
低估
0.33

預期 EV/EBITDA

低估
5 年均值 EV/EBITDA
2.88
目前EV/EBITDA
0.00
高估
4.36
低估
1.41

預期股價營收比

嚴重低估
5 年均值 P/S
0.85
目前P/S
0.00
高估
1.17
低估
0.53

事件時間軸

2026-09-11 (ET)

09:30:00

Bonk Enters Preferred Stock Redemption Agreement with Core4 to Buy Back 26,667 Shares

2026-07-29 (ET)

08:30:00

Bonk, Inc. Forms Wholly Owned Subsidiary BONK SPV LLC

2026-04-29 (ET)

08:20:00

Bonk Appoints Founder Mitchell Rudy as President

2026-04-17 (ET)

12:10:00

Bonk Inc. Files $100M Mixed Securities Shelf

2026-04-07 (ET)

08:20:00

Bonk, Inc. Q1 Revenue Reaches $3.2M, Exceeding Target by 233%

資訊

BNKK 常見問題 —— 由 Alphio AI 解答

Bonk, Inc., formerly Safety Shot, Inc., is a wellness and dietary supplement company. The Company has developed Sure Shot, which is a patented wellness product that lowers blood alcohol content. In approximately 30 minutes, this product helps the body break down alcohol. Its bottles and stick packs are sold direct-to-consumer (D2C) and via retail partners. D2C orders through the Sure Shot Website are fulfilled via a 3PL with additional sales through online outlets. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon. It has also introduced business-to-business sales of Sure Shot to distributors, retailers, restaurants and bars. It also makes energy beverages with yerba mate and other plant-based ingredients. Its energy beverages are zero calorie, zero sugar, non-genetically modified organism, vegan, kosher, keto-friendly, paleo-approved, gluten-free and diabetic-friendly. The Company is focused on building a digital asset treasury. It operates in the Consumer Non-Cyclicals sector.

Bonk Inc (BNKK) is currently trading at $1.085, which is significantly lower than its 200-day simple moving average of $2.18, indicating a bearish trend. The RSI is at 29.83, suggesting the stock is oversold, which could indicate a potential reversal. However, the stock has seen a year-to-date decline of 63.10%, and its forward P/E ratio is at 0, reflecting uncertainty about future earnings. The recent insider purchase by President Mitchell Rudy at $1.37 shows some confidence in the stock, but the overall financial performance remains concerning, with a gross margin of only 33.61% in Q2 2026 and a net income loss of $6.05 million in the same quarter. The main risk is the continued decline in stock performance, with a 5-day change of -10.33%.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易